Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pediatric acute lymphoblastic leukemia
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534

Showing 1-25 of 534 citing articles:

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, et al.
Blood (2010) Vol. 115, Iss. 16, pp. 3206-3214
Open Access | Times Cited: 754
Histone lysine methyltransferases in biology and disease
Dylan Husmann, Or Gozani
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 10, pp. 880-889
Open Access | Times Cited: 374
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
John Colicelli
Science Signaling (2010) Vol. 3, Iss. 139
Open Access | Times Cited: 337
Molecular Biomarkers in Cancer
Virinder Kaur Sarhadi, Gemma Armengol
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 283
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 137
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
Linea Natalie Toksvang, Shawn H. R. Lee, Jun J. Yang, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1749-1758
Open Access | Times Cited: 85
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Shawn H. R. Lee, Wenjian Yang, Yoshihiro Gocho, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 170-179
Open Access | Times Cited: 54
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial
Myriam Campbell, Csongor Kiss, Martin Zimmermann, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 19, pp. 3499-3511
Closed Access | Times Cited: 46
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 44
Personalized medicine: new genomics, old lessons
Kenneth Offit
Human Genetics (2011) Vol. 130, Iss. 1, pp. 3-14
Open Access | Times Cited: 204
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications
Qingshan Huang, Xin Liang, Tingting Ren, et al.
Cellular Oncology (2021) Vol. 44, Iss. 3, pp. 525-539
Closed Access | Times Cited: 76
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Shunsuke Kimura, Charles G. Mullighan
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3792-3792
Open Access | Times Cited: 75
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
Katrina Rack, Jolien De Bie, Geneviève Ameye, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 5, pp. 548-561
Open Access | Times Cited: 55
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
Monika Lejman, Aleksandra Chałupnik, Zuzanna Chilimoniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2755-2755
Open Access | Times Cited: 55
Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing
Lucas B. Pontel, Alberto Bueno-Costa, Agustín E. Morellato, et al.
Redox Biology (2022) Vol. 55, pp. 102408-102408
Open Access | Times Cited: 47
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
Marta Malczewska, Kamil Kośmider, Kinga Bednarz, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2021-2021
Open Access | Times Cited: 41
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Alanna J. Church, Laura Corson, Pei‐Chi Kao, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1581-1589
Closed Access | Times Cited: 39
CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 28
Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
Hiroshi Hayashi, Atsushi Makimoto, Yuki Yuza
Cancers (2024) Vol. 16, Iss. 4, pp. 723-723
Open Access | Times Cited: 13
Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes
John Choi, Wenbin Xiao, Xueyan Chen, et al.
Modern Pathology (2024) Vol. 37, Iss. 5, pp. 100466-100466
Closed Access | Times Cited: 11
The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia
Ben Watts, Christopher M. Smith, Kathryn L. Evans, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia
Gloria Hidalgo‐Gómez, Bárbara Tazón‐Vega, Carlos Palacio, et al.
Annals of Hematology (2025)
Open Access | Times Cited: 1
Presence of minimal residual disease determined by next-generation sequencing is not a reliable prognostic biomarker in children with acute lymphoblastic leukemia
Elizabeta Krstevska Bozhinovikj, Nadica Matevska-Geshkovska, Marija Staninova Stojovska, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-8
Open Access | Times Cited: 1
Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
Lu Jin, Yinghui Guan, Xue Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1083-1103
Open Access | Times Cited: 1
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial
Valentino Conter, Maria Grazia Valsecchi, Daniela Silvestri, et al.
The Lancet (2007) Vol. 369, Iss. 9556, pp. 123-131
Closed Access | Times Cited: 114
Page 1 - Next Page

Scroll to top